Chemical Properties
| Melting point | 132-134℃ |
| Boiling point | 596.4±45.0 °C(Predicted) |
| Density | 1.097±0.06 g/cm3(Predicted) |
| storage temp. | 2-8°C |
| solubility | DMSO:77.5(Max Conc. mg/mL);282.47(Max Conc. mM) Ethanol:28.0(Max Conc. mg/mL);102.06(Max Conc. mM) Water:55.0(Max Conc. mg/mL);200.47(Max Conc. mM) |
| pka | 14.19±0.10(Predicted) |
| InChI | InChI=1S/C13H26N2O4/c16-10-8-14-12(18)6-4-2-1-3-5-7-13(19)15-9-11-17/h16-17H,1-11H2,(H,14,18)(H,15,19) |
| InChIKey | PAHZPHDAJQIETD-UHFFFAOYSA-N |
| SMILES | C(NCCO)(=O)CCCCCCCC(NCCO)=O |
Usage And Synthesis
[1] Cordaro M, et al. Adelmidrol, a Palmitoylethanolamide Analogue, as a New Pharmacological Treatment for the Management of Inflammatory Bowel Disease. BIOCHEMICAL PHARMACOLOGY, 2016; 90: 549-561
[2] Fusco R, et al. Adelmidrol: A New Promising Antioxidant and Anti-Inflammatory Therapeutic Tool in Pulmonary Fibrosis. Antioxidants, 2020; 9.
[3] Guida F, et al. Targeting Neuroinflammation in Osteoarthritis with Intra-Articular Adelmidrol. 2022; 12.
[2] Fusco R, et al. Adelmidrol: A New Promising Antioxidant and Anti-Inflammatory Therapeutic Tool in Pulmonary Fibrosis. Antioxidants, 2020; 9.
[3] Guida F, et al. Targeting Neuroinflammation in Osteoarthritis with Intra-Articular Adelmidrol. 2022; 12.
